Practicing internal medicine physician who has served as chairman and CEO of the Virginia Mason Health System in Seattle since 2000. He is also chair of the National Patient Safety Foundation Lucian Leape Institute and immediate past chair of the Institute for Healthcare Improvement Board of Directors. During his tenure as chief executive, Virginia Mason has become a national leader in quality, safety and innovation resulting from its Toyota Production System-inspired lean management methodology, the Virginia Mason Production System. To schedule an interview with Dr. Kaplan, contact Virginia Mason Media Relations.
Sr. Director, Medication Safety & QualityASHP (American Society of Health-System Pharmacists)
drug shortages, Opioids, Medication Safety, Patient Safety, Pediatrics, Critical Care, hospital administration, Healthcare, Pharmacy, Polypharmacy
Deborah A. Pasko, Pharm.D., M.H.A., is the Sr. Director of Medication Safety and Quality at ASHP (American Society of Health-System Pharmacists). With more than 22 years of pharmacy practice experience, Dr. Pasko leads ASHP’s efforts to improve medication safety and reduce opioid misuse.
Dr. Pasko’s role at ASHP includes working with the Food and Drug Administration (FDA), the National Institutes of Health (NIH), the Department of Health and Human Services (HHS), and the White House on national medication safety initiatives. She also serves as an advisor to the Institute for Safe Medication Practices (ISMP), the Joint Commission (TJC), the United States Pharmacopeia (USP) National Coordinating Council for Medication Error Reporting and Prevention (NCC-MERP) safety committee, and the National Quality Forum (NQF).
Dr. Pasko earned her Bachelor of Pharmacy degree from the Ohio Northern University College of Pharmacy and her Doctor of Pharmacy degree from Idaho State University College of Pharmacy. She has a Masters of Health Administration from the Walden University School of Health Sciences and completed a fellowship in Nephrology and Critical Care at the University of Michigan College of Pharmacy. Dr. Pasko has received numerous awards including the Cheers Award for Medication Safety.
Associate Professor of Accounting, Health Policy, and ManagementJohns Hopkins University Carey Business School
healthcare administration, finace, Accounting, healthcare pricing, Healthcare Management, Health Policy, Healthcare Access, healthcare business, healthcare decision making, Healthcare economics, healthcare information, Healthcare Law
Ge Bai, PhD, CPA is an associate professor of Accounting at Johns Hopkins Carey Business School and associate professor of Health Policy & Management at Johns Hopkins Bloomberg School of Public Health. She is an expert on health care pricing, policy, and management. Dr. Bai has testified before House Ways and Means Committee, written for the Wall Street Journal, and published her studies in leading academic journals such as the New England Journal of Medicine, JAMA, JAMA Internal Medicine, Annals of Internal Medicine, and Health Affairs. Her work has been widely featured in ABC, Atlantic, CBS, CNN, Forbes, Fox News, Los Angeles Times, NBC, New York Times, NPR, The Guardian, U.S. News & World Report, Wall Street Journal, Washington Post, and other media and used in government regulations and congressional testimonies.
Co-director of the Hutchinson Institute for Cancer Outcomes Research (HICOR) at Fred HutchFred Hutchinson Cancer Research Center
Healthcare economics, healthcare economist, cost of healthcare, Cost of Care, cost of cancer care, Cancer Cost, value-based cancer care, Financial toxicity, financial toxicity of cancer, Drug Costs, Healthcare Costs
Dr. Veena Shankaran is a medical oncologist and healthcare economist whose research focuses on the cost of cancer care and how it impacts patients and their families. A nationally recognized physician-scientist, her current research is investigating the out-of-pocket costs that patients with gastrointestinal cancers experience as well as the cost-effectiveness of cancer therapy—studying how great care can be delivered without wasting resources. Along with Dr. Scott Ramsey, Dr. Shankaran co-directs the Hutchinson Institute for Cancer Outcomes Research (HICOR) at the Fred Hutchinson Cancer Research Center in Seattle, researching and assessing the cost effectiveness of healthcare and health-related quality of life. In addition to her role as co-director of HICOR, she is an associate member of the Public Health Sciences and Clinical Research divisions at Fred Hutch. She also serves as associate professor of Medical Oncology at the University of Washington School of Medicine.
Senior lead for health care quality and policy, HICORFred Hutchinson Cancer Research Center
Healthcare economics, cost of cancer care, cancer costs, value-based cancer care, Financial toxicity, Drug Costs, cost-effective cancer care, HICOR, disparities in cancer care, biosimilars, cancer outcomes, Hutchinson Institute for Cancer Outcomes Research
While many researchers worldwide are trying to find cures for cancer, Dr. Gary Lyman has an equally daunting task: finding a cure for cancer’s skyrocketing costs and the financial toll it can take on patients and their families. Dr. Lyman is an internationally recognized thought leader in cancer care delivery, supportive care and health care policy. His research compares the effectiveness of novel diagnostic and therapeutic strategies; examines clinical decision-making; explores risk modeling and precision medicine; assesses health technology research and synthesis; and delves into the factors that drive disparities in cancer care. In 2018, he co-co-authored a New England Journal of Medicine paper on biosimilars and what their imminent debut might mean for cancer patients, the health care industry and society. He also led an American Society of Clinical Oncology (ASCO) panel that published a position statement on biosimilars in the Journal of Clinical Oncology. A medical oncologist, hematologist and public health researcher who focuses on comparative effectiveness, health technology assessment, and health services and outcomes research, he also is interested in cancer prevention, pharmaco-economics, and cancer treatment and supportive care for the elderly. Dr Lyman is among the top 1% of investigators by citations in Web of Science. In addition to his work at the Hutch, Dr. Lyman holds leadership positions within the American Society of Clinical Oncology as well as the SWOG Cancer Research Network, for which he serves as executive officer for Cancer Care Delivery, Symptom Control and Quality of Life Research. Dr. Lyman serves as a senior lead for health care quality and policy within the Hutchinson Institute for Cancer Outcomes Research, or HICOR.
The founding director of the Business, Education and Community Outreach Network (BEACON) in Salisbury University’s Franklin P. Perdue School of Business, Dr. Memo Diriker is an economic trend analysist with expertise in healthcare policy and economics, as well as local and state government economics. Through BEACON, he also has overseen analyses on growing regional Hispanic and elderly populations, as well as the economic benefits of agriculture. BEACON, The Business Economic and Community Outreach Network, of the Franklin P. Perdue School of Business at Salisbury University, offers business, economic, workforce, and community development consulting and assistance services to a variety of organizations, including businesses, government agencies, and non-profit community-based organizations. At BEACON, Diriker advises a large number of private, public, and nonprofit sector organizations, specializing in the use of scenario analysis and in demographic, business and economic trend forecasting. He oversees the organization’s initiatives, including Bienvenidos a Delmarva, ShoreENERGY, GrayShore and ShoreTrends. He has served as the principal investigator on numerous grants and sponsored research projects, totaling over $10 million in awards. In addition to a book, he has authored many articles in academic and practitioner publications, and is a sought-after public speaker.
As President and CEO, Elizabeth Mitchell advances the organization’s strategic focus areas of redesigning health care delivery, driving affordability, and optimizing markets. Mitchell leads PBGH in mobilizing purchasers, to support high-quality affordable care – achieving measurable impacts on health outcomes and affordability including quality, patient-reported outcomes and satisfaction, and the appropriateness of delivered care. At PBGH, Mitchell leverages her extensive experience in working with healthcare purchasers, providers, policymakers, and payers to improve quality and cost. Mitchell previously served as Senior Vice President for Healthcare and Community Health Transformation at Blue Shield of California, during which time she designed Blue Shield’s strategy for transforming practice, payment and community health. Mitchell also served as the President and CEO of the Network for Regional Healthcare Improvement (NRHI), a network of regional quality improvement and measurement organizations; served as CEO of Maine’s business coalition on health (the Maine Health Management Coalition); worked within an integrated delivery system (MaineHealth); and was elected to the Maine State Legislature, serving as a State Representative. Mitchell served as Vice Chairperson of the U.S. Department of Health & Human Services Physician-Focused Payment Model Technical Advisory Committee, Board and Executive Committee Member of the National Quality Forum (NQF), Member of the National Academy of Medicine’s “Vital Signs” Study Committee on core metrics, and a Guiding Committee Member for the Health Care Payment Learning & Action Network. Mitchell holds a degree in religion from Reed College and studied social policy at the London School of Economics.
Assistant Professor Of Pediatrics Director Of Pediatric Antimicrobial Stewardship For McGovern Medical School And Children's Memorial Hermann HospitalUniversity of Texas Health Science Center at Houston
Process Improvement, Healthcare Quality, Patient Safety